SCHEMBL1480070

SCHEMBL1480070

C[C@H]1CO[C@H]2[C@@H]1OC[C@H]2O[Si](C)(C)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1480360 1.00 — —
SCHEMBL1480361 1.00 — —
SCHEMBL16930857 1.00 — —
SCHEMBL16930858 1.00 — —
SCHEMBL1480072 1.00 — —
SCHEMBL6670981 0.90 ALDH1A1 (0.34) —
SCHEMBL16968556 0.80 THRB (0.46) —
SCHEMBL21570693 0.80 THRB (0.46) —
SCHEMBL20859865 0.80 THRB (0.46) —
SCHEMBL15054823 0.80 THRB (0.46) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150209349-A1 Piperazine Compounds AMURA THERAPEUTICS LTD (GB) 2015-07-30 — — US disclosed
US-9045492-B2 Piperazine compounds AMURA THERAPEUTICS LIMITED (GB) 2015-06-02 — — US disclosed
US-20130252969-A1 Compounds AMURA THERAPEUTICS LIMITED (GB) 2013-09-26 — — US disclosed
US-8501744-B2 Piperazine compounds AMURA THERAPEUTICS, LIMITED (GB) 2013-08-06 — — US disclosed
US-20110077254-A1 COMPOUNDS AMURA THERAPEUTICS LIMITED (GB) 2011-03-31 — — US disclosed
Send feedback